Get the Stockscreener App
59.00
2.90%
1.66
After Hours:
60.35
1.35
+2.29%
Sol Gel Technologies Ltd stock is traded at $59.00, with a volume of 5,586.
It is up +2.90% in the last 24 hours and up +40.98% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
See More
Previous Close:
$57.34
Open:
$56.42
24h Volume:
5,586
Relative Volume:
0.30
Market Cap:
$164.36M
Revenue:
$23.93M
Net Income/Loss:
$-3.41M
P/E Ratio:
-51.75
EPS:
-1.14
Net Cash Flow:
$-33.87M
1W Performance:
-18.17%
1M Performance:
+40.98%
6M Performance:
+436.36%
1Y Performance:
+595.67%
1-Day Range:
$56.42
$60.35
1-Week Range:
$48.26
$75.00
52-Week Range:
$4.018
$75.00
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
59.00 | 159.74M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $64,432.98 in Stock - Defense World
Sol Gel Technologies stock price target raised to $110 from $50 at H.C. Wainwright By Investing.com - Investing.com South Africa
Sol Gel Technologies stock price target raised to $110 from $50 at H.C. Wainwright - Investing.com Nigeria
Sol-Gel Technologies (SLGL) Analyst Rating Update: Target Price Doubles | SLGL Stock News - GuruFocus
Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL) - Defense World
Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Upcoming Q4 Catalyst - Seeking Alpha
Bear Alert: Can Falcons Beyond Global Inc deliver consistent dividendsTrade Performance Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st
Value Recap: Is Sol Gel Technologies Ltd. undervalued by DCF analysisQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Inflation Data: Can Sol Gel Technologies Ltd beat the S P 500Weekly Profit Recap & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Declines By 67.2% - MarketBeat
How rising interest rates impact Sol Gel Technologies Ltd. stockJuly 2025 PostEarnings & Low Risk Entry Point Guides - ulpravda.ru
Aug Weekly: Will Sol Gel Technologies Ltd. stock gain from lower inflation2025 Top Gainers & Real-Time Chart Pattern Alerts - ulpravda.ru
Support Test: How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 WrapUp & Expert-Curated Trade Recommendations - Улправда
Can Sol Gel Technologies Ltd. stock hit record highs againJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
Is Sol Gel Technologies Ltd. stock supported by strong cash flowsJuly 2025 Chart Watch & Consistent Return Investment Signals - ulpravda.ru
How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - ulpravda.ru
Does Sol Gel Technologies Ltd. stock trade at a discount to peersTrade Signal Summary & Short-Term High Return Ideas - Улправда
Can MMP Industries Limited Regain Lost Ground This QuarterStock Liquidity Analysis & Stay Ahead With Daily Market Discussions - bollywoodhelpline.com
Siddhika Coating Limited A Paint CompanyStock Rotation Strategies & Build Diversified Portfolios With Ease - bollywoodhelpline.com
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
FinancialContentRosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - FinancialContent
Opaleye Management Inc. Buys 22,497 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Opaleye Management Inc. Acquires 35,169 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Market Moves: Why Sol Gel Technologies Ltd stock could see breakout soonAnalyst Upgrade & Weekly Top Stock Performers List - Bộ Nội Vụ
Weekly Analysts’ Ratings Changes for Sol-Gel Technologies (SLGL) - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $361,500.30 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Purchases 35,169 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $944,649.03 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $10,831.60 in Stock - MarketBeat
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys 1,019 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $67,771.68 in Stock - MarketBeat
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth - Yahoo Finance
Sol-Gel Technologies (SLGL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What is HC Wainwright's Estimate for SLGL FY2025 Earnings? - MarketBeat
What analysts say about Sol Gel Technologies Ltd stockAI-Driven Market Analysis & Small Investment Capital Gains - earlytimes.in
Sol-Gel Technologies’ (SLGL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Receives "Buy" Rating from HC Wainwright - MarketBeat
HC Wainwright & Co. Reiterates Sol-Gel Technologies (SLGL) Buy Recommendation - Nasdaq
SLGL: HC Wainwright & Co. Reiterates Buy Rating with $50 Price T - GuruFocus
What dividend safety score for Sol Gel Technologies Ltd. stockWeekly Market Summary & Free Community Supported Trade Ideas - Улправда
Will Sol Gel Technologies Ltd. stock gain from lower inflationJuly 2025 WrapUp & Community Shared Stock Ideas - Улправда
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires 2,735 Shares of Stock - MarketBeat
Owner Opaleye Management Inc Buys 2,735 ($110.4K) Of Sol-Gel Technologies Ltd [SLGL] - TradingView — Track All Markets
How analysts rate Sol Gel Technologies Ltd. stock todayJuly 2025 Chart Watch & Fast Entry High Yield Tips - bolumsonucanavari.com
Is Sol Gel Technologies Ltd. stock a buy before product launchesQuarterly Profit Report & Daily Technical Forecast Reports - DonanımHaber
Why Sol Gel Technologies Ltd. stock could see breakout soonMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Sol Gel Technologies Ltd. stock benefit from upcoming earnings reports2025 Valuation Update & Safe Capital Growth Plans - Улправда
Sol-Gel Technologies (SLGL) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Sol-Gel to End SGT-210 Trial in Darier Disease - marketscreener.com
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):